Detalhe da pesquisa
1.
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis.
Crit Rev Oncol Hematol
; 196: 104321, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460929
2.
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
J Cancer Res Clin Oncol
; 150(4): 183, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594593